POLYMERASE CHAIN REACTION MARKET ANALYSIS

Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, and Others) and Reagents and Consumables)), by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022
Code : CMI1546
Pages :150
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Increasing numbers of product launches in polymerase chain reaction are expected to drive growth of the global polymerase chain reaction market

Key players in the polymerase chain reaction market are engaged in launching advanced and novel PCR instruments and consumables, which will allows rapid and easy nucleic acid amplification. For instance, in October 2017, Diatech Pharmacogenetics S.R.L., a provider of molecular diagnostic tools for precision medicine launched easyPGX: a ready-to-use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma.

Key Players

Major players operating in the global polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation.